Pfizer is developing a twice a day Covid Pill that you will have to take everyday. The new pill is expected to be released by the end of the year.
The study of the covid pill will involve 1,140 participants and will combine the treatment, PF-07321332, with a low dose of ritonavir, which has previously been used with other antiviral medications.
The Covid pill that Pfizer is developing is a potent protease inhibitor, the same kind of technology used to treat HIV and hepatitis C according to the Hill. Preclinical studies showed the oral antiviral “demonstrated potent in vitro anti-viral activity against SARS-CoV-2, as well as activity against other coronaviruses.”
Patients will receive the treatment or a placebo orally every 12 hours for five days. PF-07321332 is designed to block the activity of the main enzyme that is needed for the virus to replicate.
How much do you trust the “fully approved” Pfizer vaccine though? Be sure to read our article about the oddities with everything surrounding the approval of the Pfizer vaccine.
